These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16170837)

  • 1. Current concepts of Down syndrome screening tests in assisted reproduction twin pregnancies: another double trouble.
    Maymon R; Neeman O; Shulman A; Rosen H; Herman A
    Prenat Diagn; 2005 Sep; 25(9):746-50. PubMed ID: 16170837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down's syndrome screening in twin pregnancies by nuchal translucency measurement. Current concept.
    Maymon R; Jauniaux E; Herman A
    Minerva Ginecol; 2002 Jun; 54(3):211-5. PubMed ID: 12063436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
    Spencer K; Nicolaides KH
    BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining nuchal translucency and serum markers in prenatal screening for Down syndrome in twin pregnancies.
    Wald NJ; Rish S; Hackshaw AK
    Prenat Diagn; 2003 Jul; 23(7):588-92. PubMed ID: 12868090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First trimester screening with free beta-hCG, PAPP-A and nuchal translucency in pregnancies conceived with assisted reproduction.
    Orlandi F; Rossi C; Allegra A; Krantz D; Hallahan T; Orlandi E; Macri J
    Prenat Diagn; 2002 Aug; 22(8):718-21. PubMed ID: 12210583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First trimester screening for Down syndrome and assisted reproduction: no basis for concern.
    Wøjdemann KR; Larsen SO; Shalmi A; Sundberg K; Christiansen M; Tabor A
    Prenat Diagn; 2001 Jul; 21(7):563-5. PubMed ID: 11494292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First trimester risk assessment for trisomy 21 in twin pregnancies combining nuchal translucency and first trimester biochemical markers.
    Prats P; Rodríguez I; Comas C; Puerto B
    Prenat Diagn; 2012 Oct; 32(10):927-32. PubMed ID: 22752980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-trimester screening markers are altered in pregnancies conceived after IVF/ICSI.
    Gjerris AC; Loft A; Pinborg A; Christiansen M; Tabor A
    Ultrasound Obstet Gynecol; 2009 Jan; 33(1):8-17. PubMed ID: 19115229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal screening for Down syndrome and neural tube defects in twin pregnancies.
    Wald NJ; Rish S
    Prenat Diagn; 2005 Sep; 25(9):740-5. PubMed ID: 16170842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down's syndrome screening in pregnancies after assisted reproductive techniques: an update.
    Maymon R; Jauniaux E
    Reprod Biomed Online; 2002; 4(3):285-93. PubMed ID: 12709282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for trisomy 21 by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-14 weeks: a German multicenter study.
    von Kaisenberg CS; Gasiorek-Wiens A; Bielicki M; Bahlmann F; Meyberg H; Kossakiewicz A; Pruggmayer M; Kamin G; Fritzer E; Harris C; Arnold N;
    J Matern Fetal Neonatal Med; 2002 Aug; 12(2):89-94. PubMed ID: 12420837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down syndrome screening in assisted conception twins: an iatrogenic medical challenge.
    Ben-Ami I; Maymon R; Svirsky R; Cuckle H; Jauniaux E
    Obstet Gynecol Surv; 2013 Nov; 68(11):764-73. PubMed ID: 24193195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancies conceived using assisted reproductive technologies (ART) have low levels of pregnancy-associated plasma protein-A (PAPP-A) leading to a high rate of false-positive results in first trimester screening for Down syndrome.
    Amor DJ; Xu JX; Halliday JL; Francis I; Healy DL; Breheny S; Baker HW; Jaques AM
    Hum Reprod; 2009 Jun; 24(6):1330-8. PubMed ID: 19246467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Spencer K; Souter V; Tul N; Snijders R; Nicolaides KH
    Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.
    Cicero S; Spencer K; Avgidou K; Faiola S; Nicolaides KH
    Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivariate analysis identifies the estradiol level at ovulation triggering as an independent predictor of the first trimester pregnancy-associated plasma protein-A level in IVF/ICSI pregnancies.
    Giorgetti C; Vanden Meerschaut F; De Roo C; Saunier O; Quarello E; Hairion D; Penaranda G; Chabert-Orsini V; De Sutter P
    Hum Reprod; 2013 Oct; 28(10):2636-42. PubMed ID: 23887070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
    Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased time-to-pregnancy and first trimester Down's syndrome screening.
    Ranta JK; Raatikainen K; Romppanen J; Pulkki K; Heinonen S
    Hum Reprod; 2010 Feb; 25(2):412-7. PubMed ID: 19945962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening.
    Tsai MS; Huang YY; Hwa KY; Cheng CC; Lee FK
    J Formos Med Assoc; 2001 May; 100(5):319-25. PubMed ID: 11432311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11 to 14 weeks.
    Cicero S; Bindra R; Rembouskos G; Spencer K; Nicolaides KH
    Prenat Diagn; 2003 Apr; 23(4):306-10. PubMed ID: 12673635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.